ZVL-29167-43216
3 vaccinations
2 coded responses
18 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 770 / TX
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-17
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-18
Registered in v-safe
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-23
- 2021-04-28
- 2021-06-16
- 2021-09-15
-
2022-01-28
Dose 2 — Moderna
-
2022-03-17
Survey response — 12 months, dose 1MedDRA: Chills, Cough, Pain — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Body aches, chills, and coughMedDRA releases: 2024-11 · check-in free text available
-
2022-03-17
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-03-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-09-16
Dose 3 — Moderna
- 2022-09-20
- 2022-09-21
- 2022-09-22
- 2022-10-02
- 2022-10-09
- 2022-10-16
- 2022-10-21
- 2022-10-28
- 2022-12-16
-
2023-03-17
Survey response — 6 months, dose 3MedDRA: Oropharyngeal pain — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-17
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-03-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Janssen/Johnson & Johnson | |
| 2 | 2022-01-28 | Moderna | No |
| 3 | 2022-09-16 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-17 | Successful 2022-03-21 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2023-03-17 | Successful 2023-03-20 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 11 — 12 months, dose 1
Symptoms: Body aches, chills, and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release